3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
13
Leukemia, Biphenotypic, Acute
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Extranodal NK-T-Cell
2
Leukemia, Myeloid, Acute
2
Down Syndrome
2
Sarcoma, Myeloid
1
Recurrence
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
Rituximab
28
acalabrutinib
15
ibrutinib
14
Cyclophosphamide
13
venetoclax
10
Lenalidomide
10
CT-P10
10
zanubrutinib
9
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
fludarabine
7
Specimen Handling
7
Cytarabine
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
Peripheral Blood Stem Cell Transplantation
6
Biopsy
6
glofitamab
5
fludarabine phosphate
5
Whole-Body Irradiation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Mycophenolic Acid
4
Vincristine
3
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Etoposide
3
Doxorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Asparaginase
×
90 days
×
Clear all
No trials found.